BDTX analyst estimates

BDTX (BDTX) analyst ratings, the average price target and its range, and every firm's latest call.

BDTX analyst ratings and price targets

DateFirmCallTarget
Jan 16, 2026Piper SandlerBlack Diamond Therapeutics price target lowered to $8 from $9 at Piper Sandler$8.00
Oct 15, 2025Stifel NicolausBlack Diamond Therapeutics resumed with a Buy at Stifel$8.00
Sep 3, 2025GuggenheimBlack Diamond Therapeutics initiated with a Buy at Guggenheim$8.00
Jul 31, 2024Raymond JamesBlack Diamond Therapeutics initiated with an Outperform at Raymond James$20.00
Jun 3, 2024Piper SandlerPiper Sandler Reiterates Overweight Rating on Black Diamond Therapeutics (BDTX)$12.00
May 16, 2024H.C. WainwrightBlack Diamond price target lowered to $11 from $12 at H.C. Wainwright$11.00
Apr 8, 2024WedbushBlack Diamond Therapeutics (BDTX) PT Raised to $16 at Wedbush$16.00
Mar 18, 2024H.C. WainwrightBlack Diamond Therapeutics (BDTX) PT Raised to $12 at H.C. Wainwright$12.00